```html

Xanthelasma (Yellow Eyelid Plaques)

What is Xanthelasma (yellow eyelid plaques)?

Xanthelasma are soft, yellow‑orange, slightly raised plaques that most commonly appear on the medial (inner) corners of the upper and lower eyelids. They are composed of collections of lipid‑filled macrophages (foam cells) within the dermis. While the lesions are benign and usually painless, they can be cosmetically concerning and sometimes act as a visible clue to underlying lipid metabolism abnormalities.

The term comes from the Greek xanthos meaning “yellow” and shalmos meaning “patch”. Xanthelasma is the most frequent type of cutaneous xanthoma in adults and is seen more often in women than men, typically between the ages of 40 and 60 years. However, they can develop at any age, even in children with certain inherited lipid disorders.

Common Causes

Most cases of xanthelasma are linked to disturbances in lipid metabolism, but a variety of systemic or local factors can contribute. Below are the most frequently identified causes:

• Primary (familial) hyperlipidemia – Elevated LDL‑cholesterol or triglycerides due to genetic factors.
• Secondary hyperlipidemia – Resulting from diabetes mellitus, hypothyroidism, or obesity.
• Familial hypercholesterolemia (FH) – An autosomal dominant disorder that markedly raises LDL‑C.
• Familial combined hyperlipidemia – Increases both cholesterol and triglycerides.
• Cholesterol‑rich diet & sedentary lifestyle – Contribute to dyslipidemia that predisposes to xanthelasma.
• Liver disease – Especially cholestatic disorders (e.g., primary biliary cholangitis) that raise serum cholesterol.
• Kidney disease – Nephrotic syndrome can cause severe hyperlipidemia.
• Medication‑induced dyslipidemia – Certain drugs such as corticosteroids, cyclosporine, and retinoids.
• Hormonal changes – Post‑menopausal estrogen decline can affect lipid profiles.
• Idiopathic – In up to 30% of patients, lipid studies are normal and no clear cause is found.

Associated Symptoms

Because xanthelasma itself is a skin manifestation, it rarely causes discomfort, but it may be seen alongside:

• Other cutaneous xanthomas (e.g., tendinous, tuberous, or eruptive xanthomas).
• Signs of hyperlipidemia: chest pain, intermittent claudication, or early‑onset atherosclerotic disease.
• Systemic disease clues:
  • Weight gain, fatigue, and cold intolerance (hypothyroidism).
  • Polyuria, polydipsia, and blurred vision (diabetes mellitus).
  • Abdominal swelling, jaundice, or pruritus (cholestatic liver disease).
• Rarely, ocular irritation if lesions become large enough to rub against the cornea.

When to See a Doctor

While a single small plaque is often harmless, you should schedule an evaluation if you notice any of the following:

• Rapid growth or sudden appearance of new plaques.
• Plaques that become painful, inflamed, ulcerated, or bleed.
• Associated visual changes (blurred vision, redness, or foreign‑body sensation).
• Personal or family history of early heart disease, stroke, or known lipid disorder.
• Any systemic symptoms suggestive of diabetes, thyroid disease, or liver/kidney problems.

Diagnosis

Diagnosis is primarily clinical, but physicians often order tests to uncover underlying metabolic issues.

1. Physical Examination

• Inspection of the eyelids for characteristic soft, yellow plaques.
• Dermatologic exam of the entire skin to look for other xanthomas.
• Palpation to confirm the lesions are non‑firm and non‑tender.

2. Laboratory Studies

• Lipid panel – Total cholesterol, LDL‑C, HDL‑C, triglycerides.
• Blood glucose & HbA1c – Screen for diabetes.
• Thyroid‑stimulating hormone (TSH) – Detect hypothyroidism.
• Liver function tests – Evaluate for cholestasis.
• Renal function (creatinine, urine protein) – Rule out nephrotic syndrome.

3. Imaging (if indicated)

• Carotid ultrasound or coronary artery calcium scoring if lipid levels are markedly abnormal or if there is a strong family history of cardiovascular disease.

4. Skin Biopsy (rare)

In atypical cases, a small punch biopsy can confirm the presence of lipid‑laden foam cells and exclude malignancy.

Treatment Options

Treatment goals are twofold: (1) improve cosmetic appearance and (2) address any underlying lipid disorder to reduce cardiovascular risk.

1. Lifestyle & Medical Management of Lipids

• Dietary changes – Adopt a heart‑healthy Mediterranean or DASH diet rich in fruits, vegetables, whole grains, fish, and nuts; limit saturated fats, trans fats, and added sugars.
• Physical activity – At least 150 minutes of moderate‑intensity aerobic exercise per week.
• Weight control – Achieve a BMI < 25 kg/m² when possible.
• Pharmacologic therapy – Statins are first‑line for elevated LDL‑C; fibrates or omega‑3 fatty acids may be added for high triglycerides. PCSK9 inhibitors are an option for refractory familial hypercholesterolemia.

2. Procedural Options for the Plaques

Direct removal does not cure the underlying lipid problem, but many patients seek it for cosmetic reasons.

• Laser therapy – CO₂ or Nd:YAG lasers vaporize the lesion with minimal scarring. Requires 1–3 sessions.
• Radiofrequency (RF) ablation – Heat‑based removal, useful for shallow plaques.
• Electrosurgery (cautery) – Effective but carries higher risk of pigment changes.
• Cryotherapy – Liquid nitrogen freezes the plaque; may cause temporary discoloration.
• Surgical excision – Small, well‑defined plaques can be cut out and sutured; best for thick or raised lesions.

All procedures should be performed by a dermatologist or oculoplastic surgeon experienced with periorbital skin.

3. Home & Natural Approaches (Adjunctive)

• Topical retinoids (e.g., tretinoin) – May thin the epidermis and reduce plaque thickness, but data are limited.
• Antioxidant‑rich oils – Some anecdotal reports suggest coconut or almond oil massage improves texture; not a substitute for medical treatment.
• Sun protection – UV exposure can darken lesions; use a broad‑spectrum SPF 30+ sunscreen daily.

Prevention Tips

Because many cases are linked to dyslipidemia, preventive measures focus on maintaining healthy blood‑lipid levels.

• Get a fasting lipid profile every 4–6 years (earlier if you have risk factors).
• Follow a diet low in saturated and trans fats; incorporate soluble fiber (oats, beans, fruits).
• Exercise regularly; aim for at least 30 minutes most days.
• Maintain a healthy weight and waist circumference.
• Quit smoking – it worsens lipid abnormalities and accelerates atherosclerosis.
• Control blood sugar and blood pressure; both influence lipid metabolism.
• Take prescribed lipid‑lowering medications exactly as directed.
• Seek routine eye examinations; ophthalmologists often spot early xanthelasma during dilated exams.

Emergency Warning Signs

Key Take‑aways

Xanthelasma are benign, yellow eyelid plaques that often signal an underlying lipid abnormality. While they are generally harmless, they can indicate an increased risk for cardiovascular disease, especially when associated with high cholesterol or triglycerides. A thorough work‑up—including a lipid panel, glucose testing, and thyroid evaluation—helps identify treatable causes. Lifestyle modification and, when needed, lipid‑lowering medication are the cornerstone of long‑term management. Cosmetic removal is available via laser, electrosurgery, cryotherapy, or surgical excision, but it does not replace the need for systemic care.

References:

• Mayo Clinic. “Xanthelasma.” Updated 2023. https://www.mayoclinic.org/diseases-conditions/xanthelasma
• American Heart Association. “Understanding Cholesterol and Lipids.” 2022. https://www.heart.org/en/health-topics/cholesterol
• National Institute of Diabetes and Digestive and Kidney Diseases. “Hyperlipidemia.” 2021. https://www.niddk.nih.gov/health-information/liver-disease/hyperlipidemia
• Cleveland Clinic. “Xanthelasma: Causes, Symptoms, and Treatment.” 2023. https://my.clevelandclinic.org/health/diseases/22690-xanthelasma
• World Health Organization. “Noncommunicable diseases: Cardiovascular diseases.” 2022. https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds)

```